Pfizer CEO Albert Bourla on Covid-19 vaccine manufacturing outlook
Earlier, the company announced that it asked to ease some restrictions on supplies.
U.S. authorities are working with pharmaceutical company Pfizer to help it maximize production capacity for the COVID-19 vaccine due to potential manufacturing challenges, Health and Welfare Secretary Alex Azar told reporters..
The company itself has not yet commented, but its CEO Albert Burla told CNBC earlier this week that the company is asking the US government to use the Defense Manufacturing Act to ease some “critical supply constraints,” especially on certain components.. He did not provide additional details.
Officials did not say exactly what production problems the company faced. They said they were very familiar with the manufacturing materials and equipment needed to make vaccines, based on experience with other drug manufacturers..
“Recently, they finally briefed us on the various problems that may arise in manufacturing, and we are putting in place whatever mechanisms are needed to help them produce products for the American people,” Azar said..
Pfizer BioNTech partner Ugur Shahin told Reuters last week that the previously announced production of 100 million doses in 2020 has been cut in half, in part due to raw material supply problems.. According to him, the problems were subsequently settled and production began on a large scale..
The US government is actively negotiating with Pfizer to secure 100 million additional doses, Chief Advisor to Operation Supersonic, Dr. Moncef Sloughi, told reporters. Previously signed an option contract with Pfizer to purchase up to 500 million additional doses at an unspecified price.
The government said Wednesday that the United States has already agreed to supply 300 million doses of Pfizer / BioNTech and Moderna vaccines in the coming months. In total, it is planned to purchase 900 million doses of vaccines from different manufacturers.
Moderna vaccine expected to receive regulatory approval as early as Friday.
Eli Lilly CEO explains the supply chain of Covid-19 antibody drug Government to purchase 300,000 doses of an experimental antibody drug The US government…
By the end of July, at least another 300 million doses of vaccines will be delivered to the United States, President Joe Biden promised The Department of…
How Soon Could The FDA Approve A COVID-19 Vaccine? | TODAY A limited number of vaccine doses are expected to be available by the end of the year The US…
Biden announces purchase of 200M more doses of COVID-19 vaccines The new presidential decree aims to increase the volume of government purchases of…